For instance, structurally conserved RET-M918T and MET-M1250T cancer drivers are situated in the substrate binding C-lobe of the kinase core (Figure 6B) and are known to be associated with oncogenic activation by displaying the highest transforming potential among known RET [102]–[106] and MET mutations [107]–[110]. The gene discussed is RET; the disease is cancer.